Cardiogenic Shock Patients With High Readmission Risk Are More Likely To Undergo Palliative Care Consultation
Kimberly Chow,Eva Chau,Michael Sturniolo,Bradley Very,Ahmet Sezer,Gavin Hickey
DOI: https://doi.org/10.1016/j.cardfail.2023.10.124
IF: 6.592
2024-01-01
Journal of Cardiac Failure
Abstract:Background Cardiogenic shock (CS) has high mortality and involves complex decision-making. Palliative care consultation (PCC) clarifies goals of care, aids in symptom management, and provides psychosocial support. However, the utilization of PCC in CS patients is not well described. Methods A retrospective cross-sectional observational analysis was performed on patients admitted between 2019-2021 who met hemodynamic criteria for CS or required pharmacological or mechanical circulatory support. Patients who received VAD, cardiac transplant, or died within 24h of admission were excluded. Patients were grouped based on the presence or absence of PCC. Fisher's exact test was used to compare clinical and demographic variables and outcomes. Results Of 148 patients, 61 (41.2%) received PCC. The mean time to PCC was 21.7±89.0 days. There were no significant differences between groups in age, gender, or race; or comorbid history, including shock, HF, MI, atrial arrhythmias, PCI, CABG, ICD, or stroke. Patients receiving PCC were more likely to have longer hospitalizations (usual care =12.8±10.5 days vs PCC =17.9±13.6 days, p=0.011) and CKD (21.8% vs 39.3%, p=0.021). Patients receiving PCC were also more likely to be in cardiogenic shock from heart failure (40.2% vs 59.0%, p=0.024) as opposed to STEMI (p= 0.56) or NSTEMI (p= 0.13). There was no significant association between PCC and pharmacologic and/or mechanical circulatory support use, comfort-measures-only transition, mortality, PCI, or in-hospital cardiac arrest. There was also no association between PCC and hospital complications such as cardiac tamponade, limb ischemia, vascular complication requiring surgery, or stroke. Patients who were discharged on home inotrope (1.2% vs 27.9%, p<0.001) or hospice (0% vs 9.8%, p=0.0028) were more likely to receive PCC. Of patients who were discharged, those receiving PCC were significantly more likely to have had a cardiac rehospitalization at 1-year follow-up (18.4% vs 24.6%, p=0.021). However, there was not a significant mortality difference. Conclusions Patients with cardiogenic shock due to heart failure, a history of CKD, were being discharged on Hospice or home inotropes, or who were perceived at high risk for readmission were more likely to receive PCC. No differences were detected in demographics or pharmacologic and/or mechanical circulatory support between groups. Differences were not detected for some variables, including comfort-measures-only transition, mortality, and in-hospital complications, possibly due to small sample size or confounding variables.
cardiac & cardiovascular systems